|
name  click to compare prices |
» Shop local, ethical and at the best price on Ethishop  |
|
|
|
Subsidiaries
Locations & production
shareholder | country | % | source |
|
year | business source |
2006 | MedImmune is the sixth-largest biotechnology group in the world. | Les Echos |
|
year name | photo position; compensation source |
2003Zoth, Lota |  Chief Financial Officer; salary: 0,84 million US$;
|
2002Mott, David |  Chief Operating Officer; salary: 2,03 million US$;
|
|
year | employees <> | social impact : country source |
|
year | employees <> | social impact : country source |
|
year |   | sales | income | | buyback | source |
2003 |
| 1,05 | 0,18 | |   | billion US$ | |
2002 |
| 0,85 | -1,1 | |   | billion US$ | |
2001 |
| 0,62 | 0,15 | |   | billion US$ | |
2000 |
| 0,54 | 0,11 | |   | billion US$ | |
1999 |
| 0,38 | 0,09 | |   | billion US$ | |
|
year | financial misdemeanor | sales | income | assets | buyback | source |
|
|
|